- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 4.20 Å
- Oligo State
- hetero-3-3-3-3-3-3-3-3-mer
- Ligands
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 9 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.2: 7 residues within 4Å:- Chain A: N.107, I.108
- Chain U: Y.50, F.114, T.115
- Chain V: D.87, T.92
2 PLIP interactions:2 interactions with chain U- Hydrogen bonds: U:T.115, U:D.56, U:D.56
NAG-NAG-BMA-MAN.10: 5 residues within 4Å:- Chain A: N.355, S.357
- Ligands: NAG-NAG-BMA.9, NAG-NAG-BMA.9, NAG.42
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.13: 10 residues within 4Å:- Chain A: N.64, K.67, T.206, E.245, N.246
- Chain X: N.30, A.31, D.49, S.51, F.90
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain X- Hydrophobic interactions: A:T.206
- Hydrogen bonds: A:K.67, X:D.49, X:S.51
NAG-NAG-BMA-MAN.15: 7 residues within 4Å:- Chain D: N.58, F.114, T.115
- Chain E: D.87, T.92
- Chain I: N.107, I.108
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.58, D:T.115
NAG-NAG-BMA-MAN.23: 5 residues within 4Å:- Chain I: N.355, S.357
- Ligands: NAG-NAG-BMA.22, NAG-NAG-BMA.22, NAG.45
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.26: 10 residues within 4Å:- Chain F: N.30, A.31, D.49, S.51, F.90
- Chain I: N.64, K.67, T.206, E.245, N.246
3 PLIP interactions:2 interactions with chain I, 1 interactions with chain F- Hydrophobic interactions: I:T.206
- Hydrogen bonds: I:K.67, F:D.49, F:S.51
NAG-NAG-BMA-MAN.28: 8 residues within 4Å:- Chain M: Y.50, D.56, F.114, T.115
- Chain N: D.87, T.92
- Chain Q: N.107, I.108
2 PLIP interactions:2 interactions with chain M- Hydrogen bonds: M:T.115, M:D.56, M:D.56
NAG-NAG-BMA-MAN.36: 5 residues within 4Å:- Chain Q: N.355, S.357
- Ligands: NAG-NAG-BMA.35, NAG-NAG-BMA.35, NAG.48
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.39: 9 residues within 4Å:- Chain P: N.30, A.31, D.49, S.51, F.90
- Chain Q: N.64, K.67, E.245, N.246
2 PLIP interactions:1 interactions with chain Q, 1 interactions with chain P- Hydrogen bonds: Q:K.67, P:D.49, P:S.51
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.6: 7 residues within 4Å:- Chain A: P.182, L.231, N.232, N.346, G.348, V.414, S.415
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.19: 6 residues within 4Å:- Chain I: L.231, N.232, N.346, G.348, V.414, S.415
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.32: 6 residues within 4Å:- Chain Q: L.231, N.232, N.346, G.348, V.414, S.415
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.9: 7 residues within 4Å:- Chain A: N.332, S.333, T.341, N.355, S.357
- Ligands: NAG-NAG-BMA-MAN.10, NAG-NAG-BMA-MAN.10
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.22: 7 residues within 4Å:- Chain I: N.332, S.333, T.341, N.355, S.357
- Ligands: NAG-NAG-BMA-MAN.23, NAG-NAG-BMA-MAN.23
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.35: 6 residues within 4Å:- Chain Q: N.332, S.333, T.341, S.357
- Ligands: NAG-NAG-BMA-MAN.36, NAG-NAG-BMA-MAN.36
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.11: 18 residues within 4Å:- Chain A: T.267, R.296, H.299, N.301, S.381, T.383
- Chain U: R.103, I.104, G.106, V.108
- Chain V: S.22, N.42, N.43, N.44, P.58, G.59, S.60
- Ligands: NAG-NAG.7
2 PLIP interactions:1 interactions with chain U, 1 interactions with chain A- Hydrophobic interactions: U:V.108
- Hydrogen bonds: U:G.106, U:V.108, A:R.296, U:R.103
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.24: 18 residues within 4Å:- Chain D: R.103, I.104, G.106, V.108
- Chain E: S.22, N.42, N.43, N.44, P.58, G.59, S.60
- Chain I: T.267, R.296, H.299, N.301, S.381, T.383
- Ligands: NAG-NAG.20
3 PLIP interactions:2 interactions with chain I, 1 interactions with chain D- Hydrogen bonds: I:R.296, I:R.296, D:G.106, D:V.108, D:R.103
- Hydrophobic interactions: D:V.108
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.37: 19 residues within 4Å:- Chain M: R.103, I.104, G.106, V.108
- Chain N: S.22, N.42, N.43, N.44, P.58, G.59, S.60
- Chain Q: N.265, T.267, R.296, H.299, N.301, S.381, T.383
- Ligands: NAG-NAG.33
2 PLIP interactions:1 interactions with chain Q, 1 interactions with chain M- Hydrogen bonds: Q:R.296, M:G.106, M:V.108, M:R.103
- Hydrophobic interactions: M:V.108
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.40: 4 residues within 4Å:- Chain A: R.162, N.167
- Chain I: R.278
- Chain W: Q.76
4 PLIP interactions:1 interactions with chain W, 2 interactions with chain A, 1 interactions with chain I- Hydrogen bonds: W:Q.76, A:R.162, A:N.167, I:R.278
NAG.41: 2 residues within 4Å:- Chain A: G.323, N.324
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.324
NAG.42: 3 residues within 4Å:- Chain A: N.361
- Ligands: NAG-NAG-BMA-MAN.10, NAG-NAG-BMA-MAN.10
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.361
NAG.43: 4 residues within 4Å:- Chain G: Q.76
- Chain I: R.162, N.167
- Chain Q: R.278
3 PLIP interactions:2 interactions with chain I, 1 interactions with chain Q- Hydrogen bonds: I:R.162, I:N.167, Q:R.278
NAG.44: 2 residues within 4Å:- Chain I: G.323, N.324
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:N.324
NAG.45: 3 residues within 4Å:- Chain I: N.361
- Ligands: NAG-NAG-BMA-MAN.23, NAG-NAG-BMA-MAN.23
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:N.361
NAG.46: 4 residues within 4Å:- Chain A: R.278
- Chain O: Q.76
- Chain Q: R.162, N.167
5 PLIP interactions:2 interactions with chain Q, 1 interactions with chain A, 2 interactions with chain O- Hydrogen bonds: Q:R.162, Q:N.167, A:R.278, O:Q.76
- Hydrophobic interactions: O:Q.76
NAG.47: 2 residues within 4Å:- Chain Q: G.323, N.324
1 PLIP interactions:1 interactions with chain Q- Hydrogen bonds: Q:N.324
NAG.48: 3 residues within 4Å:- Chain Q: N.361
- Ligands: NAG-NAG-BMA-MAN.36, NAG-NAG-BMA-MAN.36
1 PLIP interactions:1 interactions with chain Q- Hydrogen bonds: Q:N.361
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kong, R. et al., Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization. Cell (2019)
- Release Date
- 2019-07-24
- Peptides
- Envelope glycoprotein gp120: AIQ
DFPH-a.15 heavy chain: BKS
DFPH-a.15 Light chain: CLT
PGT122 Heavy chain: DMU
PGT122 Light chain: ENV
VRC03 Light chain: FPX
VRC03 Heavy chain: GOW
Envelope glycoprotein gp41: HJR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
2I
CQ
cB
3K
HS
hC
4L
LT
lD
5M
MU
mE
6N
NV
nF
7P
RX
rG
8O
QW
qH
AJ
DR
d
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 4.20 Å
- Oligo State
- hetero-3-3-3-3-3-3-3-3-mer
- Ligands
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 9 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kong, R. et al., Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization. Cell (2019)
- Release Date
- 2019-07-24
- Peptides
- Envelope glycoprotein gp120: AIQ
DFPH-a.15 heavy chain: BKS
DFPH-a.15 Light chain: CLT
PGT122 Heavy chain: DMU
PGT122 Light chain: ENV
VRC03 Light chain: FPX
VRC03 Heavy chain: GOW
Envelope glycoprotein gp41: HJR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
2I
CQ
cB
3K
HS
hC
4L
LT
lD
5M
MU
mE
6N
NV
nF
7P
RX
rG
8O
QW
qH
AJ
DR
d